These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18204410)

  • 1. Therapeutic possibility of "Semax" for depression.
    Pae CU
    CNS Spectr; 2008 Jan; 13(1):20-1. PubMed ID: 18204410
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of chronic Semax administration on exploratory activity and emotional reaction in white rats].
    Vilenskiĭ DA; Levitskaia NG; Andreeva LA; Alfeeva LIu; Kamenskiĭ AA; Miasoedov NF
    Ross Fiziol Zh Im I M Sechenova; 2007 Jun; 93(6):661-9. PubMed ID: 17850024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome.
    Tsai SJ
    Med Hypotheses; 2007; 68(5):1144-6. PubMed ID: 16996699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The heptapeptide SEMAX stimulates BDNF expression in different areas of the rat brain in vivo.
    Dolotov OV; Seredenina TS; Levitskaya NG; Kamensky AA; Andreeva LA; Alfeeva LY; Nagaev IY; Zolotarev YA; Grivennikov IA; Engele Y; Myasoedov NF
    Dokl Biol Sci; 2003; 391():292-5. PubMed ID: 14556513
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of Semax on dopaminergic and serotoninergic systems of the brain.
    Eremin KO; Kudrin VS; Grivennikov IA; Miasoedov NF; Rayevsky KS
    Dokl Biol Sci; 2004; 394():1-3. PubMed ID: 15088389
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of semax on the temporary dynamics of brain-derived neurotrophic factor and nerve growth factor gene expression in the rat hippocampus and frontal cortex].
    Agapova TIu; Agniullin IaV; Silachev DN; Shadrina MI; Slominskiĭ PA; Shram SI; Limborskaia SA; Miasoedov NF
    Mol Gen Mikrobiol Virusol; 2008; (3):28-32. PubMed ID: 18756821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of semax and its C-end peptide PGP on expression of the neurotrophins and their receptors in the rat brain during incomplete global ischemia].
    Stavchanskiĭ VV; Tvorogova TV; Botsina AIu; Skvortsova VI; Limborskaia SA; Miasoedov NF; Dergunova LV
    Mol Biol (Mosk); 2011; 45(6):1026-35. PubMed ID: 22295573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of dopaminergic and stimulant drugs for the treatment of depression.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Feb; 50(2):11-4. PubMed ID: 22263621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serotonin and antidepressant treatments: new issues about the therapeutic mechanism of action].
    Lista Varela A
    Vertex; 2003; 14(51):25-9. PubMed ID: 12690406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of antidepressant and stimulant use on switching from depression to mania in children.
    Craney J; Geller B
    J Child Adolesc Psychopharmacol; 2003; 13(2):201-4. PubMed ID: 12880514
    [No Abstract]   [Full Text] [Related]  

  • 11. Methylphenidate and depression.
    Ng B
    J Clin Psychopharmacol; 2008 Feb; 28(1):116-7; author reply 117-8. PubMed ID: 18204360
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relationship between the therapeutic effect of the peptide preparation semax and the severity of brain ischemia].
    Khugaeva VK; Aleksandrin VV
    Biull Eksp Biol Med; 1997 Jul; 124(7):39-42. PubMed ID: 9303728
    [No Abstract]   [Full Text] [Related]  

  • 13. Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain.
    Dolotov OV; Karpenko EA; Seredenina TS; Inozemtseva LS; Levitskaya NG; Zolotarev YA; Kamensky AA; Grivennikov IA; Engele J; Myasoedov NF
    J Neurochem; 2006 Apr; 97 Suppl 1():82-6. PubMed ID: 16635254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus.
    Dolotov OV; Karpenko EA; Inozemtseva LS; Seredenina TS; Levitskaya NG; Rozyczka J; Dubynina EV; Novosadova EV; Andreeva LA; Alfeeva LY; Kamensky AA; Grivennikov IA; Myasoedov NF; Engele J
    Brain Res; 2006 Oct; 1117(1):54-60. PubMed ID: 16996037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-deficit hyperactivity disorder and brain-derived neurotrophic factor: a speculative hypothesis.
    Tsai SJ
    Med Hypotheses; 2003 Jun; 60(6):849-51. PubMed ID: 12699711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the efficacy of semax in global cerebral ischemia in vivo].
    Iakovleva EV; Kuzenkov VS; Fedorov VN; Skvortsova VI; Koshelev VB; Gusev EI; Ashmarin IP
    Biull Eksp Biol Med; 1999 Aug; 127(8):172-4. PubMed ID: 11188738
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanisms of action of antidepressive drugs: new approaches].
    David DJ
    Encephale; 2012 Dec; 38 Suppl 2():S45-8. PubMed ID: 23279957
    [No Abstract]   [Full Text] [Related]  

  • 18. Is there a role for psychostimulants in old age depression and apathy?
    Ng B
    Int Psychogeriatr; 2009 Apr; 21(2):417-8. PubMed ID: 19216822
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel therapeutics for depression: L-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent.
    Stahl SM
    CNS Spectr; 2007 Oct; 12(10):739-44. PubMed ID: 17934378
    [No Abstract]   [Full Text] [Related]  

  • 20. [The efficacy of semax in the tretament of patients at different stages of ischemic stroke].
    Gusev EI; Martynov MY; Kostenko EV; Petrova LV; Bobyreva SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(3. Vyp. 2):61-68. PubMed ID: 29798983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.